Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial-Reference-Cited by-同舟云学术

Comparison of 10 and 14 days of antofloxacin-based versus 14 days of clarithromycin-based bismuth quadruple therapy for Helicobacter pylori eradication: A randomized trial

Published:2023-01 Issue:1 Volume:47 Page:102052
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

He Xiao-Jian,Wang Xiao-Ling,Huang Xiao-Yan,Li Da-Zhou,Liu Gang,Wang Wen^ORCID,Li Dong-Liang

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Pathobiology of helicobacter pylori-induced gastric cancer;Amieva;Gastroenterology,2016

2. A deep neural network improves endoscopic detection of early gastric cancer without blind spots;Wu;Endoscopy,2019

3. Primary antibiotic resistance of helicobacter pylori in China;Hu;Dig Dis Sci,2017

4. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study;Zhang;World J Gastroenterol,2015

5. Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers;Xiao;Biopharm Drug Dispos,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of 10-day versus 14-day bismuth-containing quadruple therapy for H. pylori eradication: A systematic review and meta-analysis;2024-08-20

2. Bismuth-based quadruple therapy versus standard triple therapy for the eradication of Helicobacter pylori in Belgium: a multicentre, non-blinded randomized, prospective study;Acta Gastro Enterologica Belgica;2024-06

3. Bismuth-based quadruple therapy versus standard triple therapy for the eradication of Helicobacter pylori in Belgium: a multicentre, non-blinded randomized, prospective study;ACTA GASTRO-ENT BELG;2024

4. Colloidal bismuth pectin‐containing quadruple therapy as the first‐line treatment of Helicobacter pylori infection: A multicenter, randomized, double‐blind, non‐inferiority clinical trial;Helicobacter;2023-03-31